End federal taxpayer support for research using fetal tissue obtained from abortions, prohibit solicitation of such tissue, and close loopholes allowing aborted fetal tissue in federally funded research.

This legislation would end taxpayer support of any research using fetal tissue obtained from an abortion as well as the solicitation of such tissue. It would also close any loopholes in the law allowing for the use of body parts obtained via abortion in federally funded research projects.

Onder introduced legislation intended to end taxpayer support for research using fetal tissue from abortions and close loopholes allowing such tissue in federally funded research.

Congressman Onder Introduces Bill to End the Trafficking of Aborted Babies | Representative Bob Onder
primary · press_release · model gpt-5.5

AP reported that the Trump administration announced human fetal tissue derived from abortions can no longer be used in research funded by the National Institutes of Health. The report said the policy covers all NIH-funded research and reverses Biden-era rollbacks, with NIH Director Jay Bhattacharya saying the agency would seek alternative approaches.

This is the clearest federal action in the lookback period showing NIH ending taxpayer support for abortion-derived fetal tissue research. It strongly supports a partial-to-near-complete fulfillment of the pledge, but the report does not specifically document a solicitation ban or other loophole-closure language.

partial same_term

Trump administration halts use of human fetal tissue in NIH-funded research
secondary · model gpt-5.4-mini · confidence 86%

NIH stated that, effective January 22, 2026, NIH funds are not permitted for research using human fetal tissue from elective abortions, and that the policy applies to the NIH intramural program and extramural grants, cooperative agreements, other transaction awards, and R&D contract proposals submitted after the notice.

Official NIH policy directly delivered the core federal-funding portion of the promise during Onder's current House term. It does not by itself show a broader statutory solicitation ban or all loophole closures, and it was an agency action rather than a candidate-sponsored action.

partial same_term

NIH Policy on Research Involving Human Fetal Tissue
secondary · model gpt-5.5 · confidence 96%

The NIH Grants Policy Statement says human fetal tissue excludes established human fetal cell lines; its elective-abortion HFT definition also excludes already-established human fetal cell lines, human embryonic stem cells or embryonic cell lines, and transplantation research on HFT for therapeutic purposes. It adds that NIH funds are not permitted for research using HFT from elective abortions effective January 22, 2026.

This confirms implementation of the NIH funding restriction but also shows exclusions that keep the promise from being fully delivered, especially for established fetal cell lines, embryonic stem cell lines, and transplantation research governed by statute.

partial same_term

NIH Grants Policy Statement, Section 4.1.15 Human Fetal Tissue Research
secondary · model gpt-5.5 · confidence 94%

The statute provides that the Secretary may conduct or support research on transplantation of human fetal tissue for therapeutic purposes, and that human fetal tissue may be used regardless of whether obtained after spontaneous abortion, induced abortion, or stillbirth, subject to consent and compliance requirements.

Federal statute still contains an authorization path for transplantation research using fetal tissue, including tissue obtained after induced abortion. This supports partial rather than full fulfillment of a promise to close loopholes across federally funded research.

partial unknown

42 U.S.C. § 289g-1 - Research on transplantation of fetal tissue
secondary · model gpt-5.5 · confidence 88%

Current federal law prohibits transfer of human fetal tissue for valuable consideration and prohibits certain directed-donation solicitation or acceptance for transplantation when the tissue is obtained pursuant to an induced abortion. It also prohibits solicitation or acquisition where a pregnancy was deliberately initiated to provide tissue.

Federal law already contains some solicitation and commerce prohibitions, but they are targeted, not a newly enacted broad ban on solicitation of aborted fetal tissue for federally funded research. This supports a partial assessment.

partial unknown

42 U.S. Code § 289g-2 - Prohibitions regarding human fetal tissue
secondary · model gpt-5.5 · confidence 86%

NIH's 2021 notice reversed the 2019 requirement that all NIH grant and contract applications proposing use of human fetal tissue from elective abortions be reviewed by an ethics advisory board, while reminding recipients about informed consent and laws against valuable consideration. The page states this notice was rescinded on January 22, 2026 and replaced by NOT-OD-26-028.

This establishes the pre-2026 baseline that NIH-funded elective-abortion HFT research was regulated rather than barred, and that the 2026 NIH notice changed the policy during Onder's federal term.

partial same_term

RESCINDED - Update on Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research
secondary · model gpt-5.5 · confidence 90%

The 2019 NIH notice required applicants proposing HFT research to justify use, address procurement and costs, certify compliance with laws, and undergo ethics advisory board review, but it defined exclusions including already-established human fetal cell lines, embryonic stem cells or embryonic cell lines, and transplantation research governed by statute. The notice was rescinded and replaced by NOT-OD-26-028 on January 22, 2026.

This provides official context for the earlier Trump-era restrictions and shows that exclusions and statutory carve-outs carried through the policy framework, reinforcing partial rather than complete delivery.

partial same_term

RESCINDED - Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research
secondary · model gpt-5.5 · confidence 87%

AP reported that the Trump administration announced human fetal tissue derived from abortions can no longer be used in NIH-funded research, that the new policy covers all NIH-funded research, and that NIH documents say the policy does not end use of cell lines created years ago from fetal cells.

This independently corroborates the NIH action and highlights a remaining limitation: established fetal-cell lines were not ended. It also attributes the completed action to the Trump administration and NIH, not to a legislative action by Onder.

partial same_term

Trump administration halts use of human fetal tissue in NIH-funded research
secondary · model gpt-5.5 · confidence 90%